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INTRODUCTION 
 
Despite recent improvements in diagnosis and therapy, ductal adenocarcinoma of the 
pancreas is among the five most frequent causes of cancer-related death in Europe 
and the United States, with overall 5-year survival rates of 5–6%. 1, 2 
The Cancer Statistics Review (2002–2008) from the US Surveillance Epidemiology 
and End Results showed that 53% of all patients with pancreatic cancer had 
concomitant distant metastases at the time of diagnosis; only 15–20% of the 
remaining patients were eligible for potentially curative resection, and up to 25% 
were staged as having locally advanced disease and thus were potentially 
“inoperable” because of involvement of surrounding major vessels. 3 
For patients susceptible to surgical treatment, as long as free margins are achieved, 
surgery is the only treatment which can offer prolonged survival. 4  
Whereas venous involvement, as long as venous reconstruction is possible, is a 
technically complex factor, but not determine unresectability, arterial involvement 
has long been a contraindication for surgical resection, due to a high morbility and 
mortality rate and limited oncological benefit.  
The term “borderline resectable pancreatic cancer” (BRPC) is now used commonly to 
describe pancreatic cancer involving the mesentericoportal or arterial axis, in which 
the multidisciplinary team thinks an R0 resection can likely be achieved.5 
So, preoperative staging is a particularly important step in patients with pancreatic 
cancer. Its purpose is to establish lesions which are considered borderline resectable 
(BRPC), those which require neoadjuvant treatment and cases where the tumor is 
inoperable or unresectable. 
The purpose of our study is to evaluate the correlation between computed 
tomography (CT) and pathology in “borderline resectable” pancreatic cancer and 
discuss its prognostic implications. 
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MATERIALS AND METHODS 
 
Patient population  
A total of 30 patients (12 males, 18 females; mean age 64 years-old – range 52-79) 
who had undergone surgical resection with associated vascular resection (arterial or 
arterovenous) for pancreatic ductal adenocarcinoma between February 2003 and 
January  2014 were examined retrospectively. A neoadjuvant chemotherapy was 
performed in 20 of 30 patients (16 with FOLFIRINOX treatment protocol, 4 with 
GEMOX tratment protocol), in particular in all patients included since 2008.  
 
CT examination  
All patients underwent preoperative MDCT using a 64-row scanner (Light Speed 
Plus VCT, GE Medical System, Milwaukee USA) in accordance with standardized 
evaluation protocol. 
Following basal scanning, high-concentration iodinated contrast medium (370-400) 
was injected intravenously at a flow rate of 4 mL/sec, using a dual-head pump 
injector. Post-contrastographic study included 3 phases: pancreatic phase (at 35-40 
sec), venous phase (at 70 sec) and late phase (at 180 sec). The following scanning 
parameters were used: section reconstruction 2.5-1.25mm; section interval 1.25-0.625 
mm; pitch 6 (High Speed-HS modality) or beam pitch 0.984:1; anode voltage 100-
120 kV; 300-350 mA or automatic tube current modulation (smart mA, noise index 
21); 0.6/0.8-second rotation speed; 512 matrix size. 
 
Evaluation paramaters 
Vascular involvement and evaluation of resectability 
In the evaluation of arterial infiltration, we examined the celiac axis (CA) and its 
main branches (hepatic artery -HA- and splenic artery –SA-) and the superior 
mesenteric artery (SMA).  
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The degree of vascular infiltration was defined according to the following grading 
(Fig.1), published by our group in 2007: 6 
• Grade 0: no contact between tumor and artery; 
• Grade I: focal tumor abutment on artery; 
• Grade II: ≤180° encasement (IIa) or >180° encasement (IIb) of the artery, without 
reduction of its caliber ; 
• Grade III: ≤180° encasement (IIIa) or >180° encasement (IIIb) with irregularity 
and distortion of the artery. 
Each artery’s longitudinal extent of contact with the neoplastic tissue was also 
evaluated using multiplanar reconstructions (MPR) with dedicated software 
(Advantage Windows 4.4 GE Medical System, Milwaukee USA). The same grading 
was used to examine the portal (PV), superior mesenteric (SMV), and splenic vein’s 
involvement. 
Each patient was given an overall resectability evaluation according to the criteria of 
the National Comprehensive Cancer Network (NCCN) version 2.2014. 5 
The degree of celiac ganglia involvement was defined according to the following 
grading (Fig. 2): 
• Grade I: celiac ganglia with normal appearance; 
• Grade II: enlargement of celiac ganglia with preserved morphology; 
• Grade III: enlargement of celiac ganglia with loss of their normal morphology. 
In the evaluation of the neural plexus, we examined the celiac plexus (and the hepatic 
and splenic branches) and the superior mesenteric artery neural plexus. Their 
involvement was graduated according to the following grading (Fig. 3-4): 
• Grade 1: slightly thickening of neural fibers;  
• Grade 2: a coarse tissue thickening along the course of neural plexus fibers; 
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Pathology investigations  
Resection specimens are opened and partially sectioned immediately after resection, 
to aid fixation. The presence of a stent or a named vessel (e.g. portal vein, superior 
mesenteric vein, or arteries) is noted.  
After orientation of the specimen, the common bile duct and pancreatic surgical 
margins are painted with India ink, the duodenum and common bile duct are opened, 
the ampulla of Vater is examined. The specimen may then be placed in a large 
volume of formalin and allowed to fix for 24−48 hours. 
The transection margins of the pancreatic neck, common bile duct and 
duodenum/distal stomach are sampled prior to specimen dissection. Tissue blocks are 
taken to include the tumour where it approaches or involves anatomical structures 
relevant to (UICC TNM) T-staging, e.g. duodenum, ampulla, common bile duct, the 
entire peripancreatic tissue and vessels. Similarly, samples should be taken from the 
tumour and the adjacent resection margins. It is often difficult to identify accurately 
the invasive tumour front macroscopically and, therefore, extensive sampling of the 
tumour and the adjacent margins is performed.  
When a segmental resection of the portal/superior mesenteric vein or artery is 
removed en-bloc with the pancreatoduodenectomy, the vessel with its proximal and 
distal ends are examined. 
The perivisceral adipose tissue including lymph nodes, celiac ganglia and neural 
plexus fibers are sampled. Finally, samples of the ampulla of Vater, common bile 
duct and background pancreas are taken. 
 
Statistical analysis  
Statistical data analysis was performed using JMP version 7.0 (SAS) statistics 
software.  
Statistical correlation was carried out using one-way ANOVA analysis of variance; χ-
squared test was used when appropriate to compare the distribution of individual 
variables between groups. A survival analysis was performed using Kaplan-Meyer 
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method, and statistical comparisons of different factors were performed with the 
bivariate test. The COX model was used in a multivariate analysis. A p value of .05 
or less was considered to indicate significance.  
A correlation between the presence of arterial infiltration at histology and the CT 
grade of arterial, perineural plexus and celiac ganglia involvement was evaluated. An 
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RESULTS 
 
MDCT findings  
For all patients, CT results showed no suspicion of metastasis or carcinomatosis, and 
this date was also confirmed during intraoperative evaluation. According to the 
NCCN criteria, at the CT evaluation 17/30 patients were considered borderline 
resectable and 13/30 unresectable (including 3 for suspected involvement of the 
inferior vena cava). A downstaging was observed in 9 of 20 patients after 
neoadjuvant chemotherapy treatment; in particular, all 9 cases demonstrated a 
dimensional reduction of the tumor while only 2 cases demonstrated a reduction in 
the degree of vascular involvement (from IIb to IIa). 
 
Surgery 
Pancreaticoduodenectomy (PD) was performed in 2 patients, total pancreasectomy in 
22 and  distal pancreatectomy in 6; in 13 patients (43%) was associated a 
multivisceral resection (4 adrenal glands, 9 stomach, 2 kidney, 2 transverse colon, 3 
gastric antrum). 
In all 30 patiens, 70 arteries were resected: 7 celiac axis, 19 hepatic arteries, 28 
splenic arteries and 16 superior mesenteric arteries. In particular, 4 arteries were 
resected in 1 patient, 3 arteries in 10 and 2 arteries in 17.  
The table 1 summarizes the grades assigned to arteries undergoing resection. Twelve 
arteries were considered grade 0, 11 grade I, 27 grade IIa, 8 grade IIb (3 HA, 5 
SMA), 7 grade IIIa (4 HA, 3 SA and 1 AMS) 5 grade IIIb (1HA, 3 SA, 1 SMA). 
Considering individual patients, 13 cases (45%) presented higher degree of arterial 
involvement of IIa, in 7 cases IIb, 5 cases IIIa and 5 cases IIIb. 	  	  	  	  	  	  
	   9	  
	   0	   I	   IIa	   IIb	   IIIa	   IIIb	   	  
Celiac	  artery	   1	   1	   5	   -­‐	   -­‐	   -­‐	   7	  
Hepatic	  artery	   -­‐	   2	   9	   3	   4	   1	   19	  
Splenic	  artery	   11	   7	   5	   -­‐	   2	   3	   28	  
Superior	  
mesenteric	  artery	   -­‐	   1	   8	   5	   1	   1	   16	  




In regards to the longitudinal extension of contact with the neoplastic tissue, 22 
vessels had a longitudinal contact ≥30mm, the remaining 36 a longitudinal contact 
<30mm (range 5-80mm, average 27,8mm). 
Twenty-four patients (80%) underwent a venous resection. Thirty-three veins were 
resected (24 mesenteric-portal axes, 6 left renal veins and 3 tangential resection of the 
inferior vena cava). In these cases, the CT evaluation had assigned a grade I in 3 
cases, IIa in 9 cases, IIb in 4, IIIa in 12 and IIIb in 5. 
Regarding the evaluation of the involvement of celiac ganglia (Table 2), CT assigned 
a symmetrical grade 1 to six ganglia, a symmetrical grade 2 to ten ganglia and a 
symmetrical grade 3 to two ganglia. Asymmetry was observed in 12 patients (9 with 
grade 1-2 and 3 with grade 2-3). 
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   1	   2	   3	  
1	   6	   4	   -­‐	  
2	   5	   10	   1	  








	   0	   1	   2	   3	  
0	   -­‐	   -­‐	   -­‐	   2	  
1	   1	   3	   1	   9	  
2	   5	   1	   -­‐	   3	  







For all cases, diagnosis of ductal adenocarcinoma was confirmed during the 
histological evaluation. In 30/31 (97%) of cases, a negativity of the resection margins 
(R0 resection) was obtained; only 1 case demostrated a microscopic residual disease 
(R1) at the level of pancreatic resection after a distal pancreatectomy. 
Vascular infiltration was confirmed in 12/70 (17%) resected arteries, and in 10/30 
patients (33%). In particular, no artery classified as grade 0, I or IIa during the CT 
evaluation was infiltrated (NPV=100% of infiltration). In fact, the thickening of 
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perivascular fat tissue visible at CT corresponded to perineural infiltration, without 
involvement of the arterial wall; the infiltration of the adventitia was confirmed in 4/8 
cases of arteries classified as grade IIb, 4/7 grade IIIa and in 4/5 grade IIIb (PPV= 
50%, 57% and 80% of infiltration respectively). 
Circumferential encasement of the artery (grade IIb and IIIb) showed a PPV=61% of 
infiltration while the reduction of the arterial caliber (grade IIIa and IIIb) a 
PPV=67%. 
Histological arterial infiltration and grade assigned to the artery at the CT evaluation 
was strongly correlated (p <0.0001) (Fig 5). Histological arterial infiltration was also 
significantly correlated with average involvement of celiac ganglia (p = 0.007) and 
with the overall involvement of ganglia and plexus (p = 0.004) (Fig 6). 
No correlation was demonstrated between the presence of histologic arterial 
infiltration and the longitudinal extension of the contact (p = 0.56) and between the 
group with neoadjuvant chemotherapy and the group treated with upfront surgery (p 
= 0.17). 
Of the 33 resected veins, 0/3 veins classified as grade I,  2/9 IIa, 3/4 IIb, 10/12 IIIa 
and 5/5 IIIb were infiltrated. Considering venous infiltration, both circumferential 
encasement (grade IIb and IIIb) and the reduction of the venous caliber (grade IIIa 
and IIIb) showed a PPV=88% of infiltration. No correlation was demostrated 
between venous infiltration and the use of neoadjuvant chemotherapy (p = 0.46) 
 
Survival Rates  
At the time of last follow- up, 8 patients were alive (follow-up time between 5 and 29 
months, median 18.5 months) and 22 were dead (follow-up time between 2 and 36 
months, median 10.3 months); 3/30 (10%) patients died for perioperative 
complications within 3 months after surgery, and therefore excluded from survival 
statistical analysis. 
The 6-month, 9-month and 1-year overall survival rate of the remaining 27 patients 
was 88%, 76% and 48% respectively;  only 4 (16%) patients were alive at 24 months. 
	   12	  
16/27 (59%) patients died due to recurrence after surgery (6/10 patients without 
neoadjuvant chemotherapy), 2 patients due to complications not related to the 
disease; 6/8 alive patients were free from disease (follow-up time between 4 and 29 
months; mean 18.5 months) 
In the group of patients with recurrence after surgery (18 cases), 3 had histologic 
confirmation of arteriovenous infiltration, 4 only of venous infiltration and 3 only of 
arterial infiltration; the remaining 8 cases, 3 had not performed the venous resection. 
No correlation was demostrated between survival and neoadjuvant chemotherapy 
treatment (p = 0.7), nor the type of surgery performed (p = 0.27), nor the number of 
resected arteries (p = 0.90), nor the type of vascular resection (only arterial or artero-
venous) (p = 0.21). 
Moreover, no correlation was demostrated between survival and the presence of 
arterial invasion at histology (p = 0.89) (Fig. 7) nor venous infiltration (p = 0.3). 
On the contrary, survival was significantly correlated with overall NCCN judgment 
resectability (p = 0.029) (Fig. 8) and with the presence or absence of recurrence after 
surgery (p = 0.0031) (Fig. 9). 
The months of follow-up were significantly correlated with the perineural 
involvement, and in particular ganglia involvement (p = 0.0016) (Fig. 10). 
Moreover, the presence of recurrence after surgery and death for recurrence were not 
correlated with the NCNN judgment, with the neoadjuvant chemotherapy, nor with 
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DISCUSSION 
 
According to the TNM staging system, pancreatic cancers involving the celiac axis or 
the superior mesenteric artery are staged as T4 and then clinical T4 pancreatic 
carcinoma are deemed unresectable because of presumed involvement of these 
arteries. 
The term “borderline resectable pancreatic cancer” (BRPC) was introduced to 
describe pancreatic cancer in an intermediate stage between straightforwardly 
resectable and technically unresectable disease.  
According to the last National Comprehensive Cancer Network (NCCN) guidelines 5, 
given absence of distant metastases, tumors with borderline resectability include the 
following:  
• CT findings of venous involvement of the SMV/PV, even including short-segment 
venous occlusion with proximal and distal sufficient vessel length allowing safe 
reconstruction;  
• Encasement of the gastroduodenal artery up to the HA, with either short-segment 
encasement or direct abutment of the HA without extension to the CA;  
• Tumor abutment of the SMA with no more than 180° of the vessel wall 
circumference.  
Tumors considered to be unresectable demonstrate the following:  
• Distant metastases  
• Greater than 180° SMA encasement or any celiac abutment (for tumors of the 
head) or SMA or celiac encasement greater than 180 degrees (for tumors of the 
body-tail) 
• Unreconstructible SMV/portal occlusion  
• Aortic or inferior vena cava (IVC) invasion or encasement  
In recent decades, a small number of groups have been challenge vascular criteria for 
resectability 7-10 and the exceptionally low rate of “resectability” of pancreatic cancer 
has increased because of technical advances in operative techniques and the 
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establishment of experienced high-volume centers. So, arterial resections are 
performed more frequently in extended resections of the pancreatic head or body, 
with the aim of an R0 resection.  
However, there is still no consensus on the surgical indication for arterial resection in 
cases of vascular infiltration recognized at the pre-operative imaging. 
In a meta-analysis including 26 studies (published from 1977 to 2010) with 366 
patients undergoing arterial resection and 2,243 patients without arterial resection, the 
survival analysis did not show a benefit compared to patients who underwent only 
venous resection. However, compared to patients who did not undergo resection, the 
1-year survival rate was three times greater for patients with arterial resection.  
The authors concluded that arterial resection is only justified in highly selected 
patients. 11-12 
However, the same meta-analysis showed significantly greater perioperative 
morbidity (median 53.6%) and mortality (median 11.8%) in patients undergoing 
arterial resection. 11 This conclusion agrees with similar conclusions in previous 
studies from high-volume centers, although a case-matched controlled study by 
Bachellier et al reported a similar 3-year survival rate of patients with and without 
arterial resection. 13-16  
In our series, only 3 patients (10%) subject to arterial resection died of perioperative 
complications. No correlation was found between survial rate and type of surgery (p 
= 0.27), nor the number of resected arteries (p = 0.90), nor the type of vascular 
resection (arterial or artero-venous) (p = 0.21), confirming that, in selected patients 
and in high-volume centers, the arterial resection is not associated with a greater 
perioperative mortality.  
Neoadjuvant chemotherapy has played an important role in patients with arterial 
infiltration, in order to increase the rate of R0 resection. 17,18 
Our study included a total of 30 patients who had undergone surgical resection with 
associate vascular resection (arterial or arterovenous); according to the NCCN 
criteria, at the CT evaluation, 17 patients were considered borderline resectable and 
	   15	  
13 unresectable. Neoadjuvant chemotherapy was performed in 20 patients. Histology 
demonstrated a single R1 case due to a microscopic infiltration of the pancreatic 
resection margin after left pancreatectomy.  
According to literature data, 19 a dimensional reduction of the tumor was observed in 
9 out of 20 patients; vascular downstaging was observed in only 2 cases, without any 
change in the overall resectability evaluation.  
Also, with limitations due to small sample size and to the different chemotherapy 
protocols administered to the patients, no significant difference between having 
carried out neoadjuvant chemotherapy or not, was observed – in regards to both 
presence of histological arterial infiltration and survival rate. 
Therefore, an accurate vascular staging is diriment to select patients for upfront 
surgery or neoadjuvant chemotherapy.  
Multi-detector computed tomography (MDCT) has been widely accepted as the best 
imaging technique for the diagnosis and staging of pancreatic cancer; most 
importantly, it is considered the gold standard in assessing vascular infiltration, with 
a reported diagnostic accuracy ranging from 85 to 93% (80-90% sensitivity and 89-
100% specificity), considering both arteries and veins. 20-23 
However, the accuracy of CT-based diagnosis of arterial infiltration needs to be 
evaluated critically. 24 
According to the CT-based classification developed at the M.D. Anderson Cancer 
Center, 25 specific criteria currently used for vascular (arterial and venous) invasion 
are based mostly on the extent of circumferential vessel involvement. Although a 
diagnostic sensitivity of up to 97% has been reported for arteries, the specificity 
ranges from 67%-91%. This is due to inadequate differentiation between fibrous, 
tumor-mimicking adhesion and true cancerous invasion, particularly in patients 
subject to neoadjuvant radio-chemotherapy, suggesting that patients could be 
incorrectly classified as having unresectable disease. 26-29 
Moreover, the reported inadequate diagnostic accuracy of the preoperative CT in 
arterial infiltration staging can be justified by the fact that CT grading systems of 
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vascular invasion are based on identical semiologic criteria for both veins and 
arteries, despite their different anatomical structure. In fact, in our study the 
infiltration was confirmed in 12/70 (17%) resected arteries and in 20/33 (60%) 
resected veins. On the basis of our CT grading of vascular involvement, both 
circumferential encasement (grade IIb and IIIb) and reduction of caliber (grade IIIa 
and IIIb) showed a PPV of infiltration of 88% for veins, while for arteries we 
observed a PPV of 61% grades IIb and IIIb and a PPV of 67% for grades IIIa and 
IIIb. To notice that none among the 27 arteries classified as IIa (≤180° encasament) 
resulted to be infiltrated.  
No correlation between histological infiltration and the longitudinal contact between 
the tumor and the artery was observed, even considering a cut-off ratio of 3cm (p = 
0.56). 
Therefore, in our study we observed a tendency to overestimate the arterial 
infiltration at CT, while the problem that more intensely worried the literature was 
instead the possible underestimation of arterial infiltration. The overestimation of the 
arterial involvement can be justified on the basis of the characteristic spreading of the 
ductal carcinoma along perineural plexus fibers, which originate from celiac ganglia 
and distribute around arterial structures. 30-35 This can further justify the need to use 
different criteria for grading venous and arterial infiltration in preoperative CT local 
staging.  
The development of modern imaging technology enabled to demonstrate the anatomy 
of celiac ganglia and the celiac and mesenteric perineural plexus fibers and to 
identify their pathologic appearance in case of neoplastic invasion. 36-42  
Mochizuki et al. 43 made a point-by-point imaging-pathological correlation between 
surgical specimens of pancreatic head cancer (resected en bloc with the surrounding 
vessels and connective tissues including plexus) and multiplanar reconstruction of CT 
images corresponding exactly to the pathological sections. The author identified CT 
signs suggestive of neural plexus fibers invasion, useful to decide the surgical 
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strategy, including extended resection with surrounding major vessels. However, in 
this study, no correlation with possible infiltration of the arterial wall was considered. 
Zhang et al. 44 instead demonstrated that vascular invasion was often present in the 
setting of nerve invasion and that the degree of vascular invasion was correlated with 
that of nerve invasion (P < 0.005) 
On the basis of this data, we therefore evaluated perineural plexus and celiac ganglia 
infiltration assigning each a grade from 1 to 3. We obtained a significant correlation 
between the presence of histological arterial infiltration and the overall perineural (p 
= 0.004) and celiac ganglia involvement (p = 0.007). Moreover, the perineural plexus 
infiltration is well known as one of the factors that predicts a poor prognosis for 
pancreatic cancer, with an incidence of 35-81% in patients with invasive cancer. 32,39 
In our study, no correlation between survival and histological arterial infiltration (p = 
0.89) nor venous infiltration (p = 0.3) existed, whereas we demonstrated a significant 
correlation with the overall resection judgment (p = 0.029). We also demonstrated a 
correlation between perineural involvement, particularly the involvement of the 
celiac ganglia, and months of follow-up (p = 0.0016). 
On the basis of these results, we evaluated whether the perineural involvement could 
influence the correlation between survival and NCCN resecability judgment. We 
demonstrated that all patients with a score <7 of overall perineural involvement were 
classified as “borderline resectable” with a significant survival curve (p = 0.0047), 
while the group with a score > 7 there were significant differences between “non 
resectable” and “borderline resectable” survival curves (p = 0.036) (Fig. 11). The 
infiltration of the celiac ganglia and perineural plexus played a key role in the 
preoperative staging, being a prognostic factor to be considered in patients with 
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CONCLUSION 
 
The strong tropism of ductal carcinoma for perineural spreading along arterial 
structures, justifies the need to use different criteria for grading venous and arterial 
infiltration in preoperative CT local staging; current CT grading system, originally 
developed for veins, should therefore be revised because of the many anatomic and 
structural differences between arteries and veins and the different relationships of 
these vessels with extrapancreatic nerve plexus. In addition, the involvement of 
neural plexus and celiac ganglia, being crucial in predicting arterial involvement and 
prognosis, should be reported in the preoperative CT staging to improve the accuracy 
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FIGURES 
	  
Fig. 1. Grade 0: no contact between lesion and vessel (a). Grade I: focal tumor 
abutment  on vessel (b). Grade IIa: ≤180° tumor encasement without reduction in 
caliber of the vessel (c). Grade IIb >180° tumor encasement, without reduction in 
caliber of the vessel (d). Grade IIIa: ≤180° encasement with reduction of the lumen 
(e). Grade IIIb: >180° encasement with reduction of the lumen (f). 
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Fig. 2. Celiac ganglia involvement: Grade I: celiac ganglia with normal appearance 
(a). Grade II: enlargement of celiac ganglia with preserved morphology (b). Grade 
III: enlargement of celiac ganglia with loss of their normal morphology (c). 
Fig. 3. Celiac plexus involvement: Grade 1: slightly thickening of neural fibers (a). 
Grade 2: coarse tissue thickening along the course of neural plexus fibers (b). Grade 
3: gross periarterial fat tissue involvement (c). 
 
Fig. 4. AMS plexus involvemen: Grade 1: slightly thickening of neural fibers (a). 
Grade 2: coarse tissue thickening along the course of neural plexus fibers (b). Grade 
3: gross periarterial fat tissue involvement (c). 
 




Fig. 5. Correlation between histological arterial infiltration and grade assigned to 
the artery at the CT (p <0.0001) . 	  	  	  	  
	  	  	  
Fig. 6. Correlation beetween histological arterial infiltration and total involvement of 
ganglia and plexus (p = 0.004) and average involvement of celiac ganglia (p = 
0.007).  
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Fig. 7. Comparison of survival in patients with or without histological arterial 




Fig. 8. Comparison of survival between patients classified as borderline resectable 
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Fig. 9. Comparison of survival between patients with or without recurrence after 




Fig. 10. Correlation between months of follow-up and ganglia involvement (p = 
0.0016) 
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Fig. 11. Survival curve in group with a score <7 of overall perineural involvement 
(a) (p = 0.0047). The survival curve in group with a score >7 of overall perineural 
involvement (b) demostrate a significant difference between “non resectable” and 
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